A. Mortgages 1. Can Security be granted to a foreign lender? Yes. In general, there are no restrictions on the ownership of land or the taking and enforcing of security rights by a foreign party. 2...

Information current as of February 2020 1. PROPOSED TRANSACTION STRUCTURE The Aircraft will be purchased by the Owner and leased on an operating lease basis to the Airline pursuant to the Lease. 2. SEARCHES...

Frankfurt/Main – Bruker has agreed to acquire ELITechGroup, a provider of specialty in vitro diagnostic (IVD) systems, from TecFin S.à r.l., a controlled affiliate of PAI Partners, a pre-eminent private equity firm, for EUR 870 million in cash, excluding the carved out ELITech clinical chemistry business. The transaction is expected to close in the second quarter of 2024, subject to regulatory approvals and other customary closing conditions.A team of CMS Germany headed by lead partner Dr Hendrik Hirsch acted as lead transaction counsel on this landmark transaction for Bruker's MDx business covering all M&A aspects of the transaction, IVDR and other regulatory aspects, antitrust and FDI filings, the carve out of the clinical chemistry business and support on the employee consultation processes in France and the Netherlands. ELITechGroup, with over 500 employees and over 40 active patents, develops and commercializes innovative, proprietary molecular diagnostic (MDx) systems and assays, as well as niche biomedical systems and microbiology products. Its molecular diagnostic business accounts for the majority of the to-be-acquired revenues and provides the unique sample-to-answer (S2A) instruments InGenius® and Be-Genius® in the mid-to-high throughput MDx category with PCR diagnostic assays for infections and diseases. ELITechGroup, excluding the clinical chemistry business, achieved approximately EUR 150 million in revenues in 2023. ELITechGroup generates the majority of its revenues from Europe, with significant business also in North and Latin America. Its major R&D and production sites are in Italy, the United States, France and Germany. CMS Germany Dr Hendrik Hirsch, Partner, Co-Lead Dr Jacob Siebert, Partner, Co-Lead Dr Dirk Baukholt, Principal Counsel Dr Berrit Roth-Mingram, Counsel Dr Maximilian Stark, Senior Associate, all Corporate/M&A Dr Roland Wiring, Partner Lukas Burgdorff, Associate Noah Rodenkirchen, Associate, all Regulatory & Lifesciences Dr Thomas Hirse, Part­ner Se­basti­an Vautz, Senior Associate Lisa Dietrich, Associate, all IP Dr Michael Bauer, Partner Stefan Lehr, Partner Kai Neuhaus, Partner Moritz Pottek, Counsel Dr. Denis Schlimpert, Counsel Kirsten Baubkus-Gerard, Senior Associate David Rappenglück, As­so­ci­ate Be­ne­dikt Christian Voss, Associate, all Antitrust, Competition & Trade Dr Thomas de la Motte, Partner Dr Markus Pfaff, Partner Dr André Frischemeier, Partner Hatice Aykel, Counsel Alisa Brehm, Senior Associate Thomas Schaak, Senior Associate Dr Sait Dogan, Associate, all Banking & Finance  Dr André Lippert, Part­ner Con­stan­ze Schweidtmann, Associate, both Real Estate & Public Dr Boris Alles, Partner Dr Theresa Kipp, Senior Associate, both Labor, Employment & Pensions CMS France Benoît Gomel, Partner Vincent Desbenoit, Associate Dylan Allali, all Corporate/M&A Caroline Froger-Michon, Partner Aurélie Parchet, As­so­ci­ate Ca­m­ille Baumgarten, Associate Sophie Yin, all Em­ploy­ment Claire Vannini, Partner Eleni Moraïtou, Coun­sel Lilia-Ori­ana Dif, Associate Ariane Rolin, all Competition & EU  Jean-Bap­tiste Thiénot, Partner Anaïs Arnal, Associate, both Intellectual Property Laurine Mayer, Associate, TMC Alexandre Chazot, Counsel, Banking & Fin­ance  Thi­erry Granier, Partner Renaud Grob, Partner, both Tax Arnaud Valverde, Senior Associate, Real Estate Olivier Kuhn, Partner Cécile Rebiffé, Counsel Mylène Garrouste, all Dispute Res­ol­u­tion Kawthar Ben Khelil, Coun­sel Jean-Pierre Malili, Associate, both Public law/In­fra­struc­ture CMS Italy Massimo Trentino, Partner, Corporate/M&A Maria Letizia Patania, Partner, Lifescience & Healthcare Gian Marco Lettieri, Senior Associate, Employment & Pensions Giulio Poggioli, Counsel Valerio Giuseppe Daniele, As­so­ci­ate Francesca Durante, Junior As­so­ci­ate  Arianna Toccaceli, Junior Associate, all Banking & Finance CMS Luxembourg Gérard Maitrejean, Partner Miruna Poenaru, Coun­sel Max­imili­an Helfgen, Associate, all Corporate/M&A CMS UK Jack Letson, Partner Lindsay McAllister, Associate, both Corporate/M&A David Dennis, Partner, Commercial CMS Netherlands Pieter van Duijvenvoorde, Partner Robert Jong, both Corporate/M&A Nigel Henssen Fleur van Assendelft de Coningh, both Employment Edmon Oude Elferink, Partner Marijke van der Vossen, both Antitrust, Competition & Trade CMS Serbia Radivoje Petrikić, Partner Mila Drljević, both Corporate/M&A CMS Austria Dieter Zandler, Partner Vanessa Horaceck, both Competition & EU CMS Ukraine Maria Orlyk, Partner Diana Valyeyeva CMS Turkiye Döne Yalçın, Partner Arcan Kemahlı,  Sa­ba­hat­tin Öztemiz Taner ElmasPress Con­tact presse@cms-hs. com

Frankfurt am Main, Atlanta, - CMS, led by Dr. Tobias Grau and Dr. Florian Plagemann, has comprehensively advised Commerzbank on the formation of a joint venture with Global Payments, a leading global provider of financial technologies and software solutions (here). CMS regularly advises banks and payment service providers on M&A transactions and regulatory matters, including Commerzbank's repurchase of the installment loan business from BNP Paribas. CMS Germany Dr Tobias Grau, Partner, Co-Lead Dr Florian Plagemann, Partner, Co-Lead Birgit Schlemmer, Senior Associate Dr Kai Wallisch, Partner Dr Tobias Kilian, Of Counsel Dr Marcel Hagemann, Partner Dr Christian Zielonka, Principal Counsel Carmen Hübner, Senior Associate Dr Maximilian Stark, Senior Associate Dr Miriam Bach, As­so­ci­ate Kath­rin Dengel, Associate Gustav Isele, Associate, all Corporate/M&A Dr Markus M. Pfaff, Client Relationship Partner Moritz Gerstmayr, Coun­sel Char­lotte Salathé, Counsel  Marcel Moussaoui, Associate Mohal Jennifer Egzau, Associate, all Banking & Finance Philipp Lotze, Partner Dr Michael Kraus, Partner Dr Anna Lena Füllsack, Senior As­so­ci­ate Theresa Lenger, Senior Associate, all TMC Kai Neuhaus, Partner Dr Björn Herbers, Partner Moritz Pottek, Counsel, all Antitrust, Competition & Trade Jörg Schrade, Part­ner Chris­ti­an Linseisen, Senior Associate, both Tax Dr Oliver Simon, Partner Dr Michael Rein, Principal Counsel Dr Philipp Deuchler, Senior Associate, all Labor, Employment & Pensions Commerzbank AG (Legal) Dr Benedikt Leffers (Group Legal, Head of Corporate / Regulatory Law)  Lars Kauer (Group Legal, Senior Legal Counsel, Corporate / Regulatory Law)  Markus Vetter (Group Legal, General Counsel, Technology, Data & In­fra­struc­ture) Carina Erlenwein (Group Legal, Senior Legal Counsel, Sales, Account Management, Payment Trans­ac­tions) Press Con­tact presse@cms-hs. com

Frankfurt/Main – Funds advised by DPE Deutsche Private Equity have sold the VTU Group to Altor Funds, with the VTU management team likewise selling its interest in the company. DPE is an independent...

Cologne – The managing partners of the Lässig Group and private equity investors Arcus Capital and BE-Invest have sold a majority stake in the Baben­hausen-based Lässig Group to private equity firm...

Frankfurt/Main – The shareholders of M.M. Warburg & CO Hypothekenbank AG, namely M.M. Warburg & CO (AG & Co.) KGaA (60%) and Landeskranken­hil­fe V.V.a.G. (40%), have sold all their shares in Warburg...

Frankfurt/Main – A bank consortium led by Commerzbank Ak­tiengesell­schaft and Deutsche Bank AG as coordinators and bookrunners is providing global pharmaceutical company IDT Biologika with credit financing...